Monday, July 30, 2018

ADMA Biologics initiated with a Buy at Chardan

Chardan analyst Keay Nakae initiated ADMA Biologics with a Buy and $10 price target.
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.